Cargando…

A promising strategy for overcoming MDR in tumor by magnetic iron oxide nanoparticles co-loaded with daunorubicin and 5-bromotetrandrin

To overcome both the dose-limiting side effects of conventional chemotherapeutic agents and the therapeutic failure resulting from multidrug resistance (MDR) and minimize adverse effects of chemotherapy agents, a novel chemotherapy formulation of magnetic nanoparticles co-loaded with daunorubicin an...

Descripción completa

Detalles Bibliográficos
Autores principales:	Cheng, Jian, Wang, Jun, Chen, Baoan, Xia, Guohua, Cai, Xiaohui, Liu, Ran, Ren, Yanyan, Bao, Wen, Wang, Xuemei
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove Medical Press 2011
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3215153/ https://www.ncbi.nlm.nih.gov/pubmed/22114476 http://dx.doi.org/10.2147/IJN.S24309

Ejemplares similares

Apoptotic mechanism of human leukemia K562/A02 cells induced by magnetic iron oxide nanoparticles co-loaded with daunorubicin and 5-bromotetrandrin
por: Wang, Jun, et al.
Publicado: (2011)

Synthesis and antitumor efficacy of daunorubicin-loaded magnetic nanoparticles
por: Wang, Jun, et al.
Publicado: (2011)

Magnetic nanoparticle of Fe(3)O(4) and 5-bromotetrandrin interact synergistically to induce apoptosis by daunorubicin in leukemia cells
por: Chen, Baoan, et al.
Publicado: (2009)

Reversal of multidrug resistance by magnetic Fe(3)O(4) nanoparticle copolymerizating daunorubicin and 5-bromotetrandrine in xenograft nude-mice
por: Chen, Baoan, et al.
Publicado: (2009)

Applications of daunorubicin-loaded PLGA-PLL-PEG-Tf nanoparticles in hematologic malignancies: an in vitro and in vivo evaluation
por: Bao, Wen, et al.
Publicado: (2019)

Effect of magnetic nanoparticles of Fe(3)O(4) and 5-bromotetrandrine on reversal of multidrug resistance in K562/A02 leukemic cells
por: Cheng, Jian, et al.
Publicado: (2009)

Multifunctional magnetic Fe(3)O(4) nanoparticles combined with chemotherapy and hyperthermia to overcome multidrug resistance
por: Ren, Yanyan, et al.
Publicado: (2012)

Biodegradable Periodic Mesoporous Organosilica (BPMO) Loaded with Daunorubicin: A Promising Nanoparticle‐Based Anticancer Drug
por: Mai, Ngoc Xuan Dat, et al.
Publicado: (2020)

Daunorubicin-loaded magnetic nanoparticles of Fe(3)O(4) overcome multidrug resistance and induce apoptosis of K562-n/VCR cells in vivo
por: Chen, Bao-an, et al.
Publicado: (2009)

Daunorubicin-TiO(2) nanocomposites as a “smart” pH-responsive drug delivery system
por: Zhang, Haijun, et al.
Publicado: (2012)

Reversal of multidrug resistance by magnetic Fe(3)O(4) nanoparticle copolymerizating daunorubicin and MDR1 shRNA expression vector in leukemia cells
por: Chen, Bao-an, et al.
Publicado: (2010)

Effect of magnetic nanoparticles on apoptosis and cell cycle induced by wogonin in Raji cells
por: Wang, Lei, et al.
Publicado: (2012)

Dual mechanism of daunorubicin-induced cell death in both sensitive and MDR-resistant HL-60 cells
por: Côme, M-G, et al.
Publicado: (1999)

Solid lipid nanoparticles loaded with iron to overcome barriers for treatment of iron deficiency anemia
por: Hosny, Khaled Mohamed, et al.
Publicado: (2015)

Reversal of multidrug resistance by cisplatin-loaded magnetic Fe(3)O(4) nanoparticles in A549/DDP lung cancer cells in vitro and in vivo
por: Li, Ke, et al.
Publicado: (2013)

The changes of T lymphocytes and cytokines in ICR mice fed with Fe(3)O(4) magnetic nanoparticles
por: Wang, Jun, et al.
Publicado: (2011)

Synthesis and Characterization of Quercetin–Iron Complex Nanoparticles for Overcoming Drug Resistance
por: Prestianni, Lucas, et al.
Publicado: (2023)

Intracellular targeted co-delivery of shMDR1 and gefitinib with chitosan nanoparticles for overcoming multidrug resistance
por: Yu, Xiwei, et al.
Publicado: (2015)

Adipocyte metabolism of the chemotherapy daunorubicin
por: Mittelman, Steven D., et al.
Publicado: (2018)

Effect of magnetic nanoparticles of Fe(3)O(4) and wogonin on the reversal of multidrug resistance in K562/A02 cell line
por: Cheng, Jian, et al.
Publicado: (2012)

mAb MDR1-modified chitosan nanoparticles overcome acquired EGFR-TKI resistance through two potential therapeutic targets modulation of MDR1 and autophagy
por: Zheng, Yan, et al.
Publicado: (2017)

Increased plasma membrane traffic in daunorubicin resistant P388 leukaemic cells. Effect of daunorubicin and verapamil.
por: Sehested, M., et al.
Publicado: (1987)

Nanoparticles as antibiotic-delivery vehicles (ADVs) overcome resistance by MRSA and other MDR bacterial pathogens: The grenade hypothesis
por: Alabresm, Amjed, et al.
Publicado: (2020)

Nobiletin and its derivatives overcome multidrug resistance (MDR) in cancer: total synthesis and discovery of potent MDR reversal agents
por: Feng, Senling, et al.
Publicado: (2020)

Effect of magnetic Fe(3)O(4) nanoparticles with 2-methoxyestradiol on the cell-cycle progression and apoptosis of myelodysplastic syndrome cells
por: Xia, Guohua, et al.
Publicado: (2011)

Liposomal daunorubicin as treatment for Kaposi’s sarcoma
por: Petre, Christin E, et al.
Publicado: (2007)

Interactions of Cisplatin and Daunorubicin at the Chromatin Level
por: Firouzi Niaki, Erfaneh, et al.
Publicado: (2020)

Melt electrospinning of daunorubicin hydrochloride-loaded poly (ε-caprolactone) fibrous membrane for tumor therapy
por: Lian, He, et al.
Publicado: (2017)

Casein-Based Nanoparticles: A Potential Tool for the Delivery of Daunorubicin in Acute Lymphocytic Leukemia
por: Zahariev, Nikolay, et al.
Publicado: (2023)

Multifunctional nanoparticles co-loaded with Adriamycin and MDR-targeting siRNAs for treatment of chemotherapy-resistant esophageal cancer
por: Zhang, Xiangyang, et al.
Publicado: (2022)

Overcoming MDR by Associating Doxorubicin and pH-Sensitive PLGA Nanoparticles Containing a Novel Organoselenium Compound—An In Vitro Study
por: Macedo, Letícia Bueno, et al.
Publicado: (2021)

Magnetic iron oxide nanoparticle-loaded hydrogels for photothermal therapy of cancer cells
por: Ji, Yunfei, et al.
Publicado: (2023)

Albumin-based nanoparticles: a promising strategy to overcome cancer drug resistance
por: Hassanin, Islam, et al.
Publicado: (2020)

PLGA-PLL-PEG-Tf-based targeted nanoparticles drug delivery system enhance antitumor efficacy via intrinsic apoptosis pathway
por: Bao, Wen, et al.
Publicado: (2015)

Dead or alive? The manipulation of neuronal ensembles and pathways by daunorubicin
por: Bashir, Zafar Iqbal, et al.
Publicado: (2017)

Author Correction: Interactions of Cisplatin and Daunorubicin at the Chromatin Level
por: Firouzi Niaki, Erfaneh, et al.
Publicado: (2020)

Magnetic Fe(3)O(4) nanoparticles and chemotherapy agents interact synergistically to induce apoptosis in lymphoma cells
por: Jing, Hongmei, et al.
Publicado: (2010)

Surfactin-based nanoparticles loaded with doxorubicin to overcome multidrug resistance in cancers
por: Huang, Wenjing, et al.
Publicado: (2018)

Biocompatibility of Fe(3)O(4)/DNR magnetic nanoparticles in the treatment of hematologic malignancies
por: Wu, Weiwei, et al.
Publicado: (2010)

Autophagy Inhibition Enhances Daunorubicin-Induced Apoptosis in K562 Cells
por: Han, Weidong, et al.
Publicado: (2011)

Cannot write session to /tmp/vufind_sessions/sess_9to8i9ahgvueaqk4s8a14lggv3